Edition:
United States

Profile: Bristol-Myers Squibb Co (BMY.N)

BMY.N on New York Stock Exchange

63.36USD
22 Sep 2017
Change (% chg)

$0.03 (+0.05%)
Prev Close
$63.33
Open
$63.33
Day's High
$63.53
Day's Low
$63.05
Volume
1,116,434
Avg. Vol
1,823,434
52-wk High
$63.74
52-wk Low
$46.01

Bristol-Myers Squibb Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. The Company's pharmaceutical products include chemically synthesized drugs, or small molecules, and products produced from biological processes called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. The Company's products include Empliciti, Opdivo, Sprycel, Yervoy, Eliquis, Orencia, Baraclude, Hepatitis C Franchise, Reyataz Franchise and Sustiva Franchise. It offers products for a range of therapeutic classes, which include virology, including human immunodeficiency virus (HIV) infection; oncology; immunoscience, and cardiovascular. Its products are sold to wholesalers, retail pharmacies, hospitals, government entities and the medical profession across the world.

Company Address

Bristol-Myers Squibb Co

345 PARK AVE
NEW YORK   NY   10154
P: +1212.5464000
F: +1302.6555049

Company Web Links